On Autism’s Trail
A new microarray that can simultaneously detect 500,000 or more specific genetic variations, covering almost every gene in the genome, will provide better insights into the complex genetic bases of many illnesses. Using the chip from Santa Clara, CA-based Affymetrix (a similar one is made by San Diego-based Illumina), researchers worldwide are seeking genetic causes of diseases such as autism, diabetes, and Alzheimer’s. Below is a sampling of these efforts. Emily Singer
Disease
U.S. sufferers
Status
Autism
1 million to 1.5 million
Genetic data from 3,700 people with autism are now being analyzed.
Alzheimer’s
4.5 million
Genetic data have been collected from 1,645 Alzheimer’s patients. Results from analysis are expected late this year or in early 2007.
Type 1 and type 2
diabetes
20.7 million
Early results from a study of 2,000 sufferers of each diabetes type are expected by early 2007.
Hypertension
65 million
Early results from a study of 2,000 sufferers are expected by early 2007.
Keep Reading
Most Popular
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
Surgeons have successfully tested a pig’s kidney in a human patient
The test, in a brain-dead patient, was very short but represents a milestone in the long quest to use animal organs in human transplants.
Is everything in the world a little bit conscious?
The idea that consciousness is widespread is attractive to many for intellectual and, perhaps, also emotional
reasons. But can it be tested? Surprisingly, perhaps it can.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
Stay connected
Illustration by Rose WongGet the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.